ASX/ADN (ASX/ADN)

Australian Securities Exchange: ASX/ADN · AUD

A$0.01

-0.00 (-16.7%)· Recorded snapshot

Market cap	25.7M
Net income (ttm)	-105M
EPS (ttm)	-A$0.02
Shares out	5.1B
Volume	2,185,780
Beta	2.09

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -105M
EPS (ttm): -A$0.02
Market cap: 25.7M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-93.7

P25 n/aP50 n/aP75 n/a

ROIC-58.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ASX/ADN indicators

Market & fundamental data

Available fields

169

Groups with data

Currency

AUD

Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2027-03-12
Enterprise value	AUD 22.6M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	1993
Industry	Other Industrial Metals & Mining
Is primary listing	Yes
ISIN number	AU000000ADN0
Last earnings date	2025-09-26
Last refreshed	2026-10-30
Last stock split date	2017-04-19
Last stock split type	Forward
Market cap	AUD 25.7M
Next earnings date	2027-03-12
Price	AUD 0.01
Price currency	AUD
Sector	Materials
SIC code	1000
Stock price date	2026-10-30
Symbol	asx/ADN
Website	https://www.andromet.com.au

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-482%
FCF / EV yield	-62.65%
FCF yield	-55.22%
Industry forward P/E	16.44x
Industry P/E	20.67x
P/B ratio	0.39x
Price / tangible book value	0.39x
Sector forward P/E	15.63x
Sector P/E	22x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROA	-57.66%
ROA (5Y)	-14.41%
ROCE	-157.91%
ROE	-93.72%
ROE (5Y)	-23.43%
ROIC	-58.58%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	0
Net income growth quarters	1
Net income growth years	0
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -9M
Depreciation and amortization	AUD 99.1M
EBIT	AUD -105.3M
EBITDA	AUD -6.2M
EPS	AUD -0.02
FCF per share	AUD -0.00
Financing cash flow	AUD 12.8M
Free cash flow	AUD -14.2M
Free cash flow minus SBC	AUD -14.6M
Investing cash flow	AUD -11.5M
Net borrowing	AUD -214,960
Net cash flow	AUD -3.9M
Net income	AUD -105M
Operating cash flow minus SBC	AUD -5.6M
Operating income	AUD -105.3M
Stock-based compensation	AUD 450,199

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	AUD 0.01
Debt / equity	0
Long-term assets	AUD 63.1M
Long-term liabilities	AUD 468,759
Net cash (debt)	AUD 3M
Net cash / market cap	11.86%
Net cash growth	-55.05%
Net debt / equity	-0.05
Piotroski F-Score	1
Property, plant and equipment	AUD 58.5M
Shareholders' equity	AUD 66.2M
Tangible book value	AUD 66.2M
Tangible book value per share	AUD 0.01
Total assets	AUD 68M
Total cash	AUD 3.2M
Total debt	AUD 150,476
Total liabilities	AUD 1.8M
WACC	15.65%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	AUD 4.9M
Current liabilities	AUD 1.4M
Current ratio	3.6
Net working capital	AUD 491,354
Quick ratio	3.5
Working capital	AUD 3.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-27.61%
Dividend per share	AUD 0.00
Last dividend	AUD 0.00
Shareholder yield	-27.61%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-64.29%
10Y return CAGR	-7.56%
10Y total return	-54.42%
150-day SMA	AUD 0.01
15Y price change	-93.34%
15Y return CAGR	-14.55%
15Y total return	-90.54%
1D price change	-16.67%
1M price change	-28.57%
1M total return	-28.57%
1Y price change	-64.29%
1Y return CAGR	-64.31%
1Y total return	-64.29%
20-day SMA	AUD 0.01
200-day SMA	AUD 0.01
20Y price change	-98.78%
20Y return CAGR	-18.36%
20Y total return	-98.27%
3M price change	-28.57%
3M total return	-28.57%
3Y price change	-76.19%
3Y return CAGR	-38.01%
3Y total return	-76.19%
50-day SMA	AUD 0.01
50-day SMA vs 200-day SMA	50under200
52-week high	AUD 0.02
52-week high date	2025-12-01
52-week low	AUD 0.01
52-week low date	2026-10-30
5Y price change	-97.14%
5Y return CAGR	-50.89%
5Y total return	-97.14%
6M price change	-37.5%
6M total return	-37.5%
All-time high	AUD 0.63
All-time high date	2005-12-12
All-time low	AUD 0.01
All-time low date	2017-06-22
Average true range (ATR)	AUD 0.00
Average volume	3.8M
Beta (1Y)	1.12
Beta (2Y)	1.39
Beta (5Y)	2.09
Change from 52-week high	-72.22%
Change from 52-week low	0%
Change from all-time high	-99.2%
Change from all-time low	0%
Change from open	-16.67%
Day's gap	0%
Dollar volume	AUD 10,929
High price	AUD 0.01
Low price	AUD 0.01
Monthly RSI	33.8
Open price	AUD 0.01
Position in 52-week range	0%
Previous close	AUD 0.01
Price vs 150-day SMA	-29.58%
Price vs 20-day SMA	-9.09%
Price vs 200-day SMA	-41.86%
Price vs 50-day SMA	-16.67%
Relative volume	0.57
RSI	42.13
Sharpe ratio	-0.24
Sharpe ratio (3Y)	0.3
Sharpe ratio (5Y)	-0.06
Sortino ratio	-0.31
Sortino ratio (3Y)	0.55
Sortino ratio (5Y)	-0.04
Volume	2.2M
Weekly RSI	30.69
YTD price change	-64.29%
YTD total return	-64.29%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4.7B
Shares change (QoQ)	12.13%
Shares change (YoY)	27.61%
Shares held by insiders	5.19%
Shares held by institutions	2.16%
Shares outstanding	5.1B

Deeper analysis on ASX/ADN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/ADN report

Is a complete ASX/ADN research report available?

No complete published report is available for asx/ADN (ASX/ADN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/ADN (ASX/ADN)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/ADN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/ADN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/ADN

Frequently asked questions